Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):257–264. doi: 10.1097/QAI.0000000000001372

Table 3.

Correlates of HIV viral suppression among 2,915 persons infected with HIV recruited across 15 cities in India

Univariable OR (95% CI) p-value Multivariable aOR* (95% CI) p-value

Number PWID injected with in past 30 days
 0–1 Ref Ref
 2–5 0.68 (0.52 − 0.89) 0.0047 0.78 (0.63 – 0.98) 0.0290
 6–10 0.71 (0.55 – 0.91) 0.0075 0.91 (0.69 – 1.19) 0.4834
 >10 0.55 (0.40 – 0.75) 0.0002 0.69 (0.53 – 0.90) 0.0063

Number of PWID known and seen in past 30 days
 1–5 Ref Ref
 6–10 1.11 (0.90 – 1.37) 0.3356 1.17 (0.95 – 1.44) 0.1377
 11 – 20 1.22 (1.01 – 1.49) 0.0434 1.20 (0.99 – 1.47) 0.0696
 >20 1.10 (0.81 – 1.48) 0.5454 1.15 (0.86 – 1.55) 0.3464

Frequency injected with multiple people
 Never Ref Ref
 Less than half the time/half 0.73 (0.59 – 0.89) 0.0025 0.85 (0.70 – 1.03) 0.0974
 More than half 0.70 (0.52 – 0.94) 0.0162 0.89 (0.69 – 1.15) 0.3762

Number of persons respondent passed needle/syringe to in past 30 days
 0 Ref Ref
 1–3 0.71 (0.53 – 0.95) 0.0220 0.88 (0.68 – 1.13) 0.3083
 >3 0.41 (0.27 – 0.61) <.0001 0.56 (0.40 – 0.79) 0.0008

Number of persons that used needle/syringe prior to respondent in past 30 days
 0 Ref Ref
 1–3 0.71 (0.50 – 1.00) 0.0525 0.87 (0.64 – 1.19) 0.3849
 >3 0.55 (0.30 – 1.01) 0.0543 0.69 (0.35 – 1.33) 0.2631

Shooting gallery in past 6 months
 No Ref Ref
 Yes 0.56 (0.44 – 0.71) <.0001 0.68 (0.56 – 0.83) 0.0068
*

Adjusted for age, sex, region, educational level, number of years injecting, injected buprenorphine in past 6 months, alcohol use (AUDIT), and social support